1.0
9 Jul 2024
Current employee, less than 1 year
Recommend
CEO approval
Business outlook
Pros
Typical pharma with all the bells and whistles
Cons
Hostile environment, nasty politics, nasty managers, currently in layoff mode, below market salary, no career advancement opportunities